A study on the combination of DC vaccine and PD-L1 inhibitor in HCC showed a synergistic effect, which can induce a stronger CD8+T cell response, increase the apoptosis of tumor cells, reduce the tumor volume, and prolong the overall survival rate of mice (145). Here, CD8A is linked to neoplasm.